Meningeal melanocytosis: A possibly useful treatment for a rare primary brain neoplasm

Journal of Neurology

Volumn 258, Issue 6, 2011, Pages 1169-1171

  Miró, Júlia ^a,b   Velasco, Roser ^a,b,d   Majós, Carles ^a,b   Gil, Miguel ^a,c   Boluda, Susana ^a,b   Bruna, Jordi ^a,b,d  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DURAN I REYNALS   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GADOLINIUM; TEMOZOLOMIDE;

ADULT; ANAMNESIS; ANTICONVULSANT THERAPY; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; BRAIN EDEMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG TOLERABILITY; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; MALE; MELANOCYTOSIS; MENINX DISORDER; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; SEIZURE; TREATMENT RESPONSE; TUMOR DIAGNOSIS;

BRAIN NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOCYTES; MENINGEAL NEOPLASMS; MENINGES; MIDDLE AGED;

EID: 79959858610     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5869-9     Document Type: Letter

References (15)

1. Brat DJ, Perry A (2007) Melanocytic lesions. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 181-183
2. H Oka T Kameya T Hata N Kawano K Fuji K Yada 1999 Leptomeningeal melanomatosis with multiple cutaneous pigmented nevi: tumor cell proliferation and malignant transformation in an autopsy case J Neurooncol 44 41 45 10582667 10.1023/A:1006127619926 1:STN:280:DC%2BD3c%2FkslCqsA%3D%3D (Pubitemid 29515648)
3. M Reyes-Mugica P Chou S Byrd V Ray M Castelli P Gattuso, et al. 1993 Nevomelanocytic proliferations in the central nervous system of children Cancer 72 2277 2285 8374887 10.1002/1097-0142(19931001)72:7<2277::AID- CNCR2820720736>3.0.CO;2-F 1:STN:280:DyaK3szos1Kltg%3D%3D (Pubitemid 23280161)
4. DJ Brat C Giannini BW Scheithauer PC Burger 1999 Primary melanocytic neoplasms of the central nervous system Am J Surg Pathol 23 745 754 10403296 10.1097/00000478-199907000-00001 1:STN:280:DyaK1MzjtVSqsg%3D%3D (Pubitemid 29307679)
5. PB Chapman LH Einhorn ML Meyers S Saxman AN Destro KS Panageas, et al. 1999 Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastasic melanoma J Clin Oncol 17 2745 2751 10561349 1:CAS:528:DyaK1MXmtlWru70%3D (Pubitemid 29415231)
6. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 15758009 10.1056/NEJMoa043330 1:CAS:528: DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
7. MR Middleton JJ Grob N Aaronson G Fierlbeck W Tilgen S Seiter, et al. 2000 Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma J Clin Oncol 18 158 166 10623706 1:CAS:528:DC%2BD3cXmtFSqsQ%3D%3D (Pubitemid 30036349)
8. R Kaufmann K Spieth U Leiter C Mauch P von den Driesch T Vogt, et al. 2005 Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from Dermatologic Cooperative Oncology Group J Clin Oncol 23 9001 9007 16260697 10.1200/JCO.2005.01.1551 1:CAS:528:DC%2BD28XktVCnsQ%3D%3D (Pubitemid 46211484)
9. M Hofmann F Kiecker R Wurm L Schlenger V Budach W Sterry, et al. 2006 Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases J Neurooncol 76 59 64 16132502 10.1007/s11060-005-2914-0 1:CAS:528:DC%2BD28Xit12itLk%3D (Pubitemid 43115761)
10. SS Agarwala JM Kirkwood M Gore B Dreno N Thatcher B Czarnetski, et al. 2004 Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study J Clin Oncol 22 2101 2107 15169796 10.1200/JCO.2004.11.044 1:CAS:528:DC%2BD2cXpsVWlsLg%3D (Pubitemid 41095143)
11. MJ Paul Y Summers AH Calvert G Rustin MH Brampton N Thatcher, et al. 2002 Effect of temozolomide on central nervous system relapse in patients with advanced melanoma Melanoma Res 12 175 178 11930115 10.1097/00008390-200204000- 00011 1:CAS:528:DC%2BD38XjslCqsrw%3D (Pubitemid 34478459)
12. WJ Hwu E Lis JH Menell KS Panageas LA Lamb J Merrell, et al. 2005 Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study Cancer 103 2590 2597.7 15861414 10.1002/cncr.21081 1:CAS:528:DC%2BD2MXlvVCkur4%3D (Pubitemid 40800539)
13. G Martin-Blondel A Rousseau AL Boch P Cacoub D Sène 2009 Primary pineal melanoma with leptomeningeal spreading: case report and review of the literature Clin Neuropathol 28 387 394 19788056 1:STN:280:DC%2BD1Mnls1ShsQ%3D%3D
14. MC Chamberlain M Glantz MD Groves WH Wilson 2009 Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment Semin Oncol 36 Suppl 2 S35 S45 19660682 10.1053/j.seminoncol.2009.05.005
15. L Ngo M Nei J Glass 2006 Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma Epilepsia 47 1237 1238 16886989 10.1111/j.1528-1167.2006.00597.x (Pubitemid 44086761)